AnaptysBio (ANAB) Stock Highlights

36.57 | -2.48%

2024-09-19 03:11:08

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.

Statistics

Range Today

36.5 38.04

Volume Today 231.1K

Range 1 Year

13.36 41.31

Volume 1 Year 76.84M

Range 3 Year

13.36 41.31

Volume 3 Year 198.16M

Range 10 Year

10 134

Volume 10 Year 620.96M

Highlights

Market Capitalization 1.22B (small)

Floating Shares 17.91M

Current Price 36.57

Price To Earnings -6.06

Price To Revenue 35.42

Price To Book 112.03

Earnings Per Share -6.35

Payout Ratio 0%

Performance

Latest -2.48%

1 Month +8.9%

3 Months +57.9%

6 Months +56.95%

1 Year +86.58%

3 Years +37.38%

5 Years -18.26%

10 Years +128.56%

Benchmarks

Market Capitalization

153 / 368

Gross Profits

222 / 278

Total Revenue

169 / 300

Total Rank

289 / 368

Free Cashflow

238 / 352

Performance 5 years

143 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.